References
- Bach A, Férézou J, Frey A. Phospholipid-rich particles in commercial parenteral fat emulsions. An overview. Prog Lipid Res 1996; 35: 133–153
- Cui FD, Shi K, Zhang LQ, Tao AJ, Kawashima YJ. Biodegradable nanoparticles loaded with insulin–phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation. J Contr Rel 2006; 114: 242–250
- Férézou J, Lai NT, Leray C, Hajri T, Frey A, Cabaret Y, Courtieu J, Lutton C, Bach A. Lipid composition and structure of commercial parenteral emulsions. Biochim Biophys Acta 1994; 1213: 149–158
- Groves MJ, Wineberg M, Brain APR. The presence of liposomal material inphosphatide stabilized emulsions. J Dispers Sci Technol 1985; 2: 237–243
- Han J, Washington C. Partition of antimicrobial additives in an intravenous emulsion and their effect on emulsion physical stability. Int J Pharm 2005; 288: 263–271
- He HB, Tang X, Cui FD. Pharmacokinetic study of ketoprofen isopropyl ester-loaded lipid microspheres in rat blood using microdialysis. Biol Pharm Bull 2006; 29: 841–845
- Herrera AM, Scott DO, Lunte CE. Microdialysis sampling for determinatin of plasma protein binding of drugs. Pharm Res 1990; 7: 1077–1081
- López-Pinto JM, González-Rodríguez ML, Rabasco AM. Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm 2005; 298: 1–12
- Michalowski CB, Guterres SS, Dalla Costa T. Microdialysis for evaluating the entrapment and release of a lipophilic drug from nanoparticles. J Pharm Biomed Anal 2004; 35: 1093–1100
- Miguez MP, Anundi I, Sainz-Pardo LA, Lindros KO. Hepatoprotective mechanism of Silymarin: no evidence for involvement of Cytochrome P450 2E1. Chem–Biol Interact 1994; 91: 51–63
- Mizushima Y, Hamano T, Yokoyama K. Use of lipid emulsions as a novel carrier for consticosteroids. J Pharm Pharmacol 1982; 34: 49–50
- Mizushima Y, Wada Y, Etoh Y, Watanabe K. Antiinflammatory effect of indomethacin ester incorporated in lipid microsphere. J Pharm Pharmacol 1983; 35: 398–399
- Patel VB, Misra AN. Encapulation and stability of clofazimine liposomes. J Microencapsulation 1999; 16: 357–367
- Patlolla RR, Vobalaboina V. Pharmacokinetics and tissue distribution of etoposide delivered in parenteral emulsion. J Pharm Sci 2005; 94: 437–445
- Tetsuo Y. Lipid microspheres as drug carriers: a pharmaceutical point of view. Adv Drug Deliv Rev 1996; 5: 117–130
- Tomas PN, Britta S, Stefan L, Martin M. Physicochemical characterization of a drug-containing phospholipid-stabilised o/w emulsion for intravenous administration. Eur J Pharm Sci 2001; 13: 393–401
- Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 1998; 172: 33–70
- Wang T, Deng YJ, Geng YH, Gao ZB, Zou JP, Wang ZX. Preparation of submicron unilamellar liposomes by freeze-drying double emulsions. Biochim Biophys Acta 2006; 1758: 222–231
- Wellington K, Jarvis B. Silymarin: a review of its clinical properties in the management of hepatic disorders. Biodrugs 2001; 15: 465–489
- Yamaguchi T. Lipid microspheres for drug delivery from the pharmaceutical viewpoint. Crit Rev Ther Drug Carrier Syst 1994; 11: 215–229